-
Barcelona, Liverpool, Bayern and Atletico reach Champions League quarter-finals
-
Tudor impressed by 'improved' Spurs despite Champions League exit
-
PSG will not relish Liverpool reunion, says Slot
-
Kane says Bayern 'don't fear anyone' ahead of Real clash
-
Venezuelan leader sacks defense minister, a Maduro stalwart
-
Kane and Bayern swat aside Atalanta to set up Real clash
-
Thailand's new parliament set to elect Anutin as PM
-
Atletico survive Spurs scare to reach Champions League quarters
-
Liverpool thrash Galatasaray to reach Champions League quarters
-
Music popstar will.i.am meshes AI and 'micromobility'
-
US Fed Chair says 'no intention' of leaving board while probe ongoing
-
US stocks fall on latest oil price surge as Fed lifts inflation forecast
-
Iran targets Gulf energy sites after intel chief killed
-
Costa Rica closes Havana embassy, tells Cuba to withdraw diplomats
-
NY's New Museum returns contemporary to heart of Manhattan
-
Cesar Chavez, icon of US labor movement, accused of serial sex abuse: report
-
Barcelona demolish Newcastle 7-2 to reach Champions League quarters
-
US Fed raises inflation outlook over 'uncertain' Iran war impact
-
Trump nominee for Homeland Security chief grilled at fiery Senate hearing
-
First international aid convoy arrives in crisis-hit Cuba
-
Eight killed during Rio police operation, including drug kingpin
-
Iran suffers new blow as Israel kills intel chief
-
Slovakia curbs diesel sales, ups prices for foreigners
-
Oscar-winner Sean Penn meets troops in frontline Ukraine
-
Thousands rally in Istanbul to mark year since mayor's arrest
-
WNBA, players union agree 'transformative' labor deal: official
-
US Fed holds rates unchanged over 'uncertain' Iran war implications
-
Senegal govt calls for investigation into Cup of Nations decision
-
From Faraja to Sepah: Iran's multiple security forces
-
Billionaire Dyson buys 50 percent stake in Bath rugby
-
Senegal demands 'corruption' probe over AFCON decision as Morocco defend appeal
-
The platypus is even weirder than thought, scientists discover
-
PSG's Barcola ruled out for several weeks with ankle injury
-
Colombia detains suspect in 2023 killing of Ecuador politician
-
Iran condemned as UN maritime body holds emergency talks on Mideast shipping
-
Iraqi Kurdish shepherds stoic in face of yet another war
-
Iran women's football team return after asylum tussle
-
US launches new era of drug war with Latin American allies
-
How many cargo ships are passing Hormuz strait?
-
'Free France': Macron reveals name of Europe's largest warship
-
Oil surges as Iran gas facilities hit, stocks slide
-
Foreign press group slams Israeli police for breaking journalist's wrist
-
Aston Villa want to be more than 'maybe team' in Europa League quest
-
McIlroy happy with back injury recovery as Masters looms
-
Vinicius 'should be loved by everyone' says Donnarumma after celebration row
-
Iran was not rebuilding nuclear enrichment, US intelligence finds
-
Carrick urges England boss Tuchel to call up United trio
-
Three sporting champions to be stripped of titles for non-doping reasons
-
Chilean GDP beats 2025 forecast despite mining dip
-
Storms, warm seas drove sudden drop in Antarctic ice: study
Who should get paid for nature's sequenced genes?
Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.
The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.
Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.
"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.
"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.
Much of the information comes from poor countries.
Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.
At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).
Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?
- 'Cheap and very fast' -
The issue is a complex one.
There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.
But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?
"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.
These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.
DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.
"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.
"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.
- Mandatory -
A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.
They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.
"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.
Another sticking point is access for Indigenous people and local communities to DSI funds.
Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.
But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.
With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.
The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.
Added Barber: "I think it's not going to all get solved here."
R.Kloeti--VB